InMed Pharmaceuticals Inc.
NASDAQINM short interest plummets 55% in one week to 1.30% of float, driven by sharp cover-down from 80,859 shares on May 8th. Stock up 9.6% weekly despite minimal short thesis; cost to borrow fell 12% to 1.65%. Availability remains abundant at 914%.
Snapshot as of 28 Jun 2026
No long-form analysis yet for INM. Pulse alerts and the live data picture are available on ORTEX.
Open INM on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for INM — free to start on ORTEX.
Sign up for free →Open INM on ORTEX